{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:08:28Z","timestamp":1791349708038,"version":"4.3.1"},"reference-count":40,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Perforin-mediated cytotoxicity is important for controlling viral infections, but also for limiting immune reactions. Failure of this cytotoxic pathway leads to hemophagocytic lymphohistiocytosis (HLH), a life-threatening disorder of uncontrolled T-cell and macrophage activation. We studied susceptibility to HLH in 2 mouse strains (souris and beigeJ) and a cohort of patients with partial defects in perforin secretion resulting from different mutations in the LYST gene. Although both strains lacked NK-cell cytotoxicity, only souris mice developed all clinical and histopathologic signs of HLH after infection with lymphocytic choriomeningitis virus. The 2 strains showed subtle differences in CTL cytotoxicity in vitro that had a large impact on virus control in vivo. Whereas beigeJ CTLs eliminated lymphocytic choriomeningitis virus infection, souris CTLs failed to control the virus, which was associated with the development of HLH. In LYST-mutant patients with Chediak-Higashi syndrome, CTL cytotoxicity was reduced in patients with early-onset HLH, whereas it was retained in patients who later or never developed HLH. Thus, the risk of HLH development is set by a threshold that is determined by subtle differences in CTL cytotoxicity. Differences in the cytotoxic capacity of CTLs may be predictive for the risk of Chediak-Higashi syndrome patients to develop HLH.<\/jats:p>","DOI":"10.1182\/blood-2011-05-356113","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T03:11:59Z","timestamp":1314760319000},"page":"4620-4629","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome"],"prefix":"10.1182","volume":"118","author":[{"given":"Birthe","family":"Jessen","sequence":"first","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Maul-Pavicic","sequence":"additional","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Ufheil","sequence":"additional","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vraetz","sequence":"additional","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Enders","sequence":"additional","affiliation":[{"name":"Ramaciotti Immunization Genomics Laboratory, John Curtin School of Medical Research, Australian National University, Acton, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[{"name":"Department of Haematology and Oncology, Children's Hospital, University of Hamburg, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"L\u00e4ngler","sequence":"additional","affiliation":[{"name":"Gemeinschaftskrankenhaus Herdecke, Department of Paediatric and Adolescent Medicine, Herdecke and University of Witten\/Herdecke, Witten, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Gross-Wieltsch","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Immunology, Klinikum Stuttgart\/Olgahospital, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bay","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology, Gaziantep University, Gaziantep, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhre","family":"Kaya","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit of the Department of Pediatrics, Medical School of Gazi University, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenan T.","family":"Bryceson","sequence":"additional","affiliation":[{"name":"Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Koscielniak","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Oncology and Immunology, Klinikum Stuttgart\/Olgahospital, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Badawy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Zagazig University, Zagazig, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Davies","sequence":"additional","affiliation":[{"name":"Immunology Department, Great Ormond Street Hospital for Children, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hufnagel","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospital Kiel, Kiel, Germany;"},{"name":"Center for Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schmitt-Graeff","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Department of General Pathology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Aichele","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology and Hygiene, Department of Immunology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"zur Stadt","sequence":"additional","affiliation":[{"name":"Centre for Diagnostics, University Medical Center, Hamburg-Eppendorf and Research Institute, Children's Cancer Center, Hamburg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"},{"name":"Institute for Transfusion Medicine, University Hospital Ulm and Institute for Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[{"name":"Center of Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111807532747700_B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.171.1.27","article-title":"Cutting edge: rapid in vivo killing by memory CD8 T cells.","volume":"171","author":"Barber","year":"2003","journal-title":"J Immunol"},{"issue":"5","key":"2019111807532747700_B2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K","article-title":"Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo.","volume":"30","author":"Barchet","year":"2000","journal-title":"Eur J Immunol"},{"issue":"12","key":"2019111807532747700_B3","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1002\/eji.1830271240","article-title":"A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.","volume":"27","author":"Ehl","year":"1997","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019111807532747700_B4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/cimm.1998.1344","article-title":"The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection.","volume":"189","author":"Ehl","year":"1998","journal-title":"Cell Immunol"},{"issue":"6","key":"2019111807532747700_B5","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1084\/jem.162.6.2125","article-title":"Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D.","volume":"162","author":"Zinkernagel","year":"1985","journal-title":"J Exp Med"},{"issue":"1","key":"2019111807532747700_B6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.134.1.608","article-title":"Mechanism of recovery from acute virus infection: I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.","volume":"134","author":"Lehmann-Grube","year":"1985","journal-title":"J Immunol"},{"issue":"9","key":"2019111807532747700_B7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1241","article-title":"T cells and viral persistence: lessons from diverse infections.","volume":"6","author":"Klenerman","year":"2005","journal-title":"Nat Immunol"},{"key":"2019111807532747700_B8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0105-2896.2005.00224.x","article-title":"Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.","volume":"203","author":"Menasche","year":"2005","journal-title":"Immunol Rev"},{"issue":"12","key":"2019111807532747700_B9","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/eji.1830251209","article-title":"The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses.","volume":"25","author":"Kagi","year":"1995","journal-title":"Eur J Immunol"},{"issue":"8","key":"2019111807532747700_B10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2803","article-title":"Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.","volume":"10","author":"de Saint Basile","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2019111807532747700_B11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.coi.2007.04.006","article-title":"Genetic defects affecting lymphocyte cytotoxicity.","volume":"19","author":"Fischer","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2019111807532747700_B12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"11","key":"2019111807532747700_B13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.187.11.1903","article-title":"Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.","volume":"187","author":"Binder","year":"1998","journal-title":"J Exp Med"},{"issue":"6475","key":"2019111807532747700_B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.","volume":"369","author":"Kagi","year":"1994","journal-title":"Nature"},{"issue":"1","key":"2019111807532747700_B15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOH.0b013e3282f2bcce","article-title":"Chediak-Higashi syndrome.","volume":"15","author":"Kaplan","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"2019111807532747700_B16","volume-title":"Record for souris: MUTAGENETIX","author":"Rutschmann","year":"2011"},{"issue":"1","key":"2019111807532747700_B17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.","volume":"33","author":"Battegay","year":"1991","journal-title":"J Virol Methods"},{"issue":"2","key":"2019111807532747700_B18","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and by drugs.","volume":"14","author":"Brunner","year":"1968","journal-title":"Immunology"},{"issue":"3","key":"2019111807532747700_B19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00007890-197003000-00005","article-title":"A microassay for cell-mediated immunity.","volume":"9","author":"Takasugi","year":"1970","journal-title":"Transplantation"},{"issue":"6285","key":"2019111807532747700_B20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/346629a0","article-title":"Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.","volume":"346","author":"Pircher","year":"1990","journal-title":"Nature"},{"issue":"6","key":"2019111807532747700_B21","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111807532747700_B22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2019111807532747700_B23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1167\/iovs.08-2791","article-title":"Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome.","volume":"50","author":"Trantow","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2019111807532747700_B24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"11","key":"2019111807532747700_B25","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/eji.200838488","article-title":"A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH).","volume":"38","author":"Pachlopnik Schmid","year":"2008","journal-title":"Eur J Immunol"},{"issue":"7","key":"2019111807532747700_B26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/pbc.22878","article-title":"A novel single point mutation of the LYST gene in two siblings with different phenotypic features of Chediak Higashi syndrome.","volume":"56","author":"Kaya","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2019111807532747700_B27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.1997.tb00969.x","article-title":"Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity.","volume":"156","author":"Zinkernagel","year":"1997","journal-title":"Immunol Rev"},{"issue":"5703","key":"2019111807532747700_B28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/278451a0","article-title":"The beige mutation in the mouse selectively impairs natural killer cell function.","volume":"278","author":"Roder","year":"1979","journal-title":"Nature"},{"issue":"4","key":"2019111807532747700_B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-3083.1980.tb00001.x","article-title":"Natural killer cell response to lymphocytic choriomeningitis virus in beige mice.","volume":"11","author":"Welsh","year":"1980","journal-title":"Scand J Immunol"},{"issue":"5","key":"2019111807532747700_B30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.151.5.1039","article-title":"Chediak-Higashi gene in humans: I. Impairment of natural-killer function.","volume":"151","author":"Haliotis","year":"1980","journal-title":"J Exp Med"},{"issue":"4","key":"2019111807532747700_B31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005792-197207000-00001","article-title":"The Chediak-Higashi syndrome: studies in four patients and a review of the literature.","volume":"51","author":"Blume","year":"1972","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2019111807532747700_B32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.151.5.1049","article-title":"Chediak-Higashi gene in humans: II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.","volume":"151","author":"Klein","year":"1980","journal-title":"J Exp Med"},{"issue":"7","key":"2019111807532747700_B33","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.4049\/jimmunol.138.7.2050","article-title":"Aberrant T cells in beige mutant mice.","volume":"138","author":"Biron","year":"1987","journal-title":"J Immunol"},{"issue":"11","key":"2019111807532747700_B34","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.4049\/jimmunol.154.11.6122","article-title":"Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.","volume":"154","author":"Baetz","year":"1995","journal-title":"J Immunol"},{"issue":"12","key":"2019111807532747700_B35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.","volume":"95","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"issue":"9","key":"2019111807532747700_B36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nri2381","article-title":"Formation and function of the lytic NK-cell immunological synapse.","volume":"8","author":"Orange","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2019111807532747700_B37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajmg.10184","article-title":"Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome.","volume":"108","author":"Karim","year":"2002","journal-title":"Am J Med Genet"},{"issue":"11","key":"2019111807532747700_B38","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/sj.jid.5700899","article-title":"Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype.","volume":"127","author":"Westbroek","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2019111807532747700_B39","first-page":"979","article-title":"Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome.","volume":"95","author":"Certain","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2019111807532747700_B40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0004.2009.01205.x","article-title":"Molecular analysis and clinical aspects of four patients with Chediak-Higashi syndrome (CHS).","volume":"76","author":"Scherber","year":"2009","journal-title":"Clin Genet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4620\/1463629\/zh804311004620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4620\/1463629\/zh804311004620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T02:29:02Z","timestamp":1686277742000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/17\/4620\/29071\/Subtle-differences-in-CTL-cytotoxicity-determine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":40,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2011,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-05-356113","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}